IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q3 2022 Holdings

Filed 2022-11-08 | 7 holdings | $68.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ventyx Biosciences Inc(VTYX)COM92332V107$26.1K746,37037.8%
Icosavax IncCOM45114M109$11.1K3,510,22816.1%
Hillevax IncCOM43157M102$9.6K558,92313.9%
Talaris Therapeutics IncCOM87410C104$7.7K2,932,60611.2%
Kezar Life Sciences IncCOM49372L100$7.1K828,71110.4%
Jasper Therapeutics IncCOM471871103$4.6K5,852,9826.7%
Elevation Oncology IncCOM28623U101$2.7K2,370,1423.9%